Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis.
about
Therapeutic potential of carbon monoxide in multiple sclerosisInteractomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesisControl of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes.Heme oxygenase-1 regulates the progression of K/BxN serum transfer arthritis.Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice.Developing drug molecules for therapy with carbon monoxide.Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs).CO and CO-releasing molecules in medicinal chemistry.The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression.Haem oxygenase-1 induction reverses the actions of interleukin-1β on hypoxia-inducible transcription factors and human chondrocyte metabolism in hypoxia.Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.Modulatory Effects of Mild Carbon Monoxide Exposure in the Developing Mouse Cochlea.Preventive effects of dietary hydroxytyrosol acetate, an extra virgin olive oil polyphenol in murine collagen-induced arthritis.Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis.Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis.
P2860
Q26999245-0247F7E7-639F-44D5-8423-42F57F42546BQ33736852-35401339-B4FB-4B4E-80ED-6456E76E8A86Q34035809-AE8A7487-8D9E-4DAF-A455-9233462B9E1BQ34533901-34F80E49-E43C-45E5-AC67-C80FB9CF12A1Q37454035-F3CF4549-4909-42FA-8DA2-8D2BFECA049BQ37986364-42119AEB-51E4-44AF-BC14-62BF86AEFE4BQ38061514-71897810-32B7-4148-B798-57FA4CE68BB2Q38077548-91B24249-2060-4B27-A6A0-CA519EB6AE45Q41854002-64C4E4FA-7F35-4A39-9B9B-B999F2568D66Q42712948-9FDF2770-8974-4073-97D4-028DD92468DEQ43629359-21AE2E65-B87E-4F77-9C92-75AA41E97918Q48060681-CCCACB67-B233-4B5F-8671-86867239FFFBQ50933999-960245CF-83EA-4AB9-8A9E-49DE36EE9EE7Q51336171-B6462B19-FE20-4664-B159-80BF1C791032Q55067876-306E310E-EB5E-496F-851E-2F19C66605A4
P2860
Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment with a CO-releasing ...... ne collagen-induced arthritis.
@en
Treatment with a CO-releasing molecule
@nl
type
label
Treatment with a CO-releasing ...... ne collagen-induced arthritis.
@en
Treatment with a CO-releasing molecule
@nl
prefLabel
Treatment with a CO-releasing ...... ne collagen-induced arthritis.
@en
Treatment with a CO-releasing molecule
@nl
P2093
P356
P1476
Treatment with a CO-releasing ...... ne collagen-induced arthritis.
@en
P2093
I Garcia-Arnandis
L A B Joosten
M C Terencio
M J Alcaraz
M L Ferrándiz
W B van den Berg
P304
P356
10.1136/ARD.2007.082412
P407
P577
2007-12-06T00:00:00Z